Status:
COMPLETED
Advisory Lead ARDS Respirator Management
Lead Sponsor:
Mathias Maleczek
Collaborating Sponsors:
Philips Austria GmbH
Medical University of Vienna
Conditions:
ARDS, Human
Eligibility:
All Genders
18-120 years
Brief Summary
A advisory will be activated in the ICUs patient data management system. The trial will be conducted as observational cohort trial. During the first six month all patients with a LIPS ≥ 4 will be incl...
Detailed Description
Background Lung protective ventilation is a well-established treatment to reduce ventilator-induced lung injury (VILI) in patients suffering from ARDS. To quantify lung protective ventilation the conc...
Eligibility Criteria
Inclusion
- LIPS \>= 4, ventilated invasively at point of screening
Exclusion
- ARDS at admission
- Pregnant patients
- Age \< 18 years
- Patients with elevated intracranial pressure
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 11 2023
Estimated Enrollment :
472 Patients enrolled
Trial Details
Trial ID
NCT04274296
Start Date
September 1 2020
End Date
January 11 2023
Last Update
October 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria, 1090